Income Statement (TTM)
Lamdong Pharmaceutical Joint Stock Company Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 273,079 | 161,902 | 171,086 | 169,250 | 182,648 | 187,415 | 180,649 | 182,592 | 187,841 | 186,001 | 188,473 | 190,793 | 191,496 | 217,958 | 233,539 | 235,837 |
| Change (%) | -40.71 | 5.67 | -1.07 | 7.92 | 2.61 | -3.61 | 1.08 | 2.88 | -0.98 | 1.33 | 1.23 | 0.37 | 13.82 | 7.15 | 0.98 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 227,158 | 140,678 | 145,610 | 141,357 | 147,855 | 149,895 | 147,218 | 148,802 | 149,386 | 148,835 | 147,197 | 143,230 | 141,410 | 153,567 | 160,485 | 161,383 |
| Change (%) | -38.07 | 3.51 | -2.92 | 4.60 | 1.38 | -1.79 | 1.08 | 0.39 | -0.37 | -1.10 | -2.69 | -1.27 | 8.60 | 4.50 | 0.56 | |
| % of Revenue | 83.18 | 86.89 | 85.11 | 83.52 | 80.95 | 79.98 | 81.49 | 81.49 | 79.53 | 80.02 | 78.10 | 75.07 | 73.84 | 70.46 | 68.72 | 68.43 |
| Gross Operating Profit | 45,921 | 21,225 | 25,476 | 27,893 | 34,793 | 37,519 | 33,432 | 33,790 | 38,455 | 37,166 | 41,276 | 47,563 | 50,087 | 64,390 | 73,054 | 74,454 |
| Change (%) | -53.78 | 20.03 | 9.48 | 24.74 | 7.84 | -10.90 | 1.07 | 13.81 | -3.35 | 11.06 | 15.23 | 5.31 | 28.56 | 13.45 | 1.92 | |
| % of Revenue | 16.82 | 13.11 | 14.89 | 16.48 | 19.05 | 20.02 | 18.51 | 18.51 | 20.47 | 19.98 | 21.90 | 24.93 | 26.16 | 29.54 | 31.28 | 31.57 |
| SG&A | 65,603 | 41,013 | 39,876 | 49,598 | 58,699 | 62,833 | 63,730 | 54,103 | 51,973 | 49,512 | 48,128 | 49,008 | 48,060 | 51,110 | 58,653 | 62,263 |
| Change (%) | -37.48 | -2.77 | 24.38 | 18.35 | 7.04 | 1.43 | -15.11 | -3.94 | -4.73 | -2.80 | 1.83 | -1.94 | 6.35 | 14.76 | 6.15 | |
| % of Revenue | 24.02 | 25.33 | 23.31 | 29.30 | 32.14 | 33.53 | 35.28 | 29.63 | 27.67 | 26.62 | 25.54 | 25.69 | 25.10 | 23.45 | 25.11 | 26.40 |
| R&D | ||||||||||||||||
| Change (%) | ||||||||||||||||
| % of Revenue | ||||||||||||||||
| OpEx | 292,761 | 181,691 | 185,486 | 190,955 | 206,555 | 212,729 | 210,947 | 202,905 | 201,359 | 198,347 | 195,325 | 192,238 | 189,469 | 204,678 | 219,138 | 223,646 |
| Change (%) | -37.94 | 2.09 | 2.95 | 8.17 | 2.99 | -0.84 | -3.81 | -0.76 | -1.50 | -1.52 | -1.58 | -1.44 | 8.03 | 7.07 | 2.06 | |
| % of Revenue | 107.21 | 112.22 | 108.42 | 112.82 | 113.09 | 113.51 | 116.77 | 111.12 | 107.20 | 106.64 | 103.64 | 100.76 | 98.94 | 93.91 | 93.83 | 94.83 |
| Operating Income | -19,682 | -19,788 | -14,400 | -21,705 | -23,906 | -25,314 | -30,298 | -20,313 | -13,518 | -12,347 | -6,852 | -1,445 | 2,027 | 13,280 | 14,401 | 12,191 |
| Change (%) | 0.54 | -27.23 | 50.73 | 10.14 | 5.89 | 19.69 | -32.96 | -33.45 | -8.66 | -44.51 | -78.91 | -240.29 | 555.08 | 8.44 | -15.34 | |
| % of Revenue | -7.21 | -12.22 | -8.42 | -12.82 | -13.09 | -13.51 | -16.77 | -11.12 | -7.20 | -6.64 | -3.64 | -0.76 | 1.06 | 6.09 | 6.17 | 5.17 |
| Interest Expense | -7,165 | -2,210 | -1,993 | -1,808 | -4,618 | -7,544 | -8,952 | -7,037 | -7,092 | -7,027 | -6,693 | -6,969 | -7,300 | -4,979 | -5,173 | -3,797 |
| Change (%) | -69.15 | -9.81 | -9.31 | 155.44 | 63.37 | 18.66 | -21.40 | 0.79 | -0.93 | -4.74 | 4.12 | 4.75 | -31.80 | 3.91 | -26.60 | |
| % of Revenue | -2.62 | -1.37 | -1.17 | -1.07 | -2.53 | -4.03 | -4.96 | -3.85 | -3.78 | -3.78 | -3.55 | -3.65 | -3.81 | -2.28 | -2.22 | -1.61 |
| Net Income | -5,153 | 37,870 | 44,478 | 29,921 | 25,319 | -38,891 | -46,886 | -29,197 | -20,238 | -20,105 | -13,554 | -9,036 | -6,075 | 6,919 | 7,756 | 7,332 |
| Change (%) | -834.89 | 17.45 | -32.73 | -15.38 | -253.60 | 20.56 | -37.73 | -30.68 | -0.66 | -32.59 | -33.33 | -32.77 | -213.89 | 12.09 | -5.46 | |
| % of Revenue | -1.89 | 23.39 | 26.00 | 17.68 | 13.86 | -20.75 | -25.95 | -15.99 | -10.77 | -10.81 | -7.19 | -4.74 | -3.17 | 3.17 | 3.32 | 3.11 |
Source: Capital IQ
